One division of a large pharmaceutical company needed help prioritizing and analyzing its product portfolio in order to make the right strategic decisions faster.
Working with Catalant
The expert has over 20 years of experience consulting with healthcare and pharmaceutical companies, including managing all aspects of the product lifecycle and maximizing commercial potential.
The expert became a de-facto member of the portfolio management team, helping prioritize innovation investments and recommending funding levels.
The organization was able to better understand and prioritize its portfolio investments and be better prepared for portfolio review cycles.
At a 40% discount versus traditional consulting firms, the organization was able to hire a highly-qualified expert for a key strategic initiative while saving an estimated $79,000 over a 3-month project.